{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:46:32Z","timestamp":1785764792968,"version":"3.56.0"},"reference-count":159,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Yunnan Key Laboratory of Integrated Traditional Chinese"},{"name":"Western Medicine for Chronic Disease in Prevention and Treatment"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Cardiac senescence is not an isolated organ decline but a systemic consequence driven by pathological crosstalk between the heart and its peripheral metabolic organs. In this review, we discard the traditional organ\u2013centric perspective and construct an integrated framework around multi-organ crosstalk axes, including the epicardial adipose tissue\u2013heart axis, the skeletal muscle\u2013heart axis, the gut\u2013heart axis, and the kidney\u2013heart axis. For each axis, we dissect the local molecular mediators\u2014inflammatory cytokines, lipotoxic metabolites, microbiota-derived compounds such as trimethylamine N-oxide (TMAO), renin-angiotensin-aldosterone system (RAAS) effectors, and extracellular vesicle (EV) cargoes\u2014and illustrate how they converge onto common pathways of oxidative stress, impaired autophagy, and cellular senescence. Importantly, we emphasize that these signals do not operate in isolation; they act synergistically through the circulation, converting local organ dysfunction into systemic cardiac aging via convergence onto shared senescence pathways. By redefining aging as a potentially modifiable multi-organ crosstalk, we propose emerging nodal points\u2014senolytics, myokine mimetics, gut microbiota modulation, RAAS\/sodium\u2013glucose cotransporter 2 (SGLT2) inhibitors, and integrated lifestyle strategies\u2014to block pathological crosstalk and delay cardiovascular aging. This framework shifts the research focus from isolated organs to systemic multi-organ crosstalk, providing new insights into cardiometabolic aging.<\/jats:p>","DOI":"10.3390\/ijms27156881","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:57:56Z","timestamp":1785761876000},"page":"6881","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2561-3861","authenticated-orcid":false,"given":"Shouyao","family":"Zhang","sequence":"first","affiliation":[{"name":"The First Clinical Medical School, Yunnan University of Chinese Medicine, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggui","family":"Xu","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical School, Yunnan University of Chinese Medicine, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Song","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5199-4656","authenticated-orcid":false,"given":"Xinghe","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical School, Yunnan University of Chinese Medicine, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/eurheartj\/ehaf231","article-title":"Healthy ageing in older adults with cardiovascular disease","volume":"46","author":"Schmanske","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/JS9.0000000000002260","article-title":"Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990\u20132021: A systematic analysis for the global burden of disease study 2021","volume":"111","author":"Li","year":"2025","journal-title":"Int. J. Surg."},{"key":"ref_3","first-page":"e65","article-title":"Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory from the American Heart Association","volume":"150","author":"Elkind","year":"2024","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.7150\/ijms.111775","article-title":"Cardiovascular System is Influenced by Skeletal Muscle-derived Extracellular Vesicles, Myokines and MicroRNAs Based on Interorgan Communication: A Systematic Review","volume":"22","author":"Chen","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Yan, H., Zhu, Y., Jiang, W., and Zhang, S. (2025). Multifactorial mechanisms of obesity-related HFpEF: The central role of epicardial adipose tissue and therapeutic perspectives. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1701459"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mih\u0103il\u0103, M., Caloian, B., Fr\u00eengu, F.I., Irimie, D.A., Minciun\u0103, I.A., and Pop, D. (2025). Beyond Traditional Risk Factors: Integrating Epicardial Adipose Tissue into the Comorbidity Landscape of HFpEF. J. Clin. Med., 14.","DOI":"10.3390\/jcm14176139"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Guo, S., Zhang, W., Cui, X., and Yin, B. (2025). The bidirectional regulatory mechanism of gut microbiota metabolites on myocardial injury in heart failure from the perspective of the gut-heart axis: A review. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1710051"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Cuervo, L., McAlpine, P.L., Olano, C., Fern\u00e1ndez, J., and Lomb\u00f3, F. (2024). Low-Molecular-Weight Compounds Produced by the Intestinal Microbiota and Cardiovascular Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910397"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/ejhf.2741","article-title":"Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: Mechanisms, management and modern perspectives","volume":"24","author":"Westenbrink","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lodewijks, F., McKinsey, T.A., and Robinson, E.L. (2023). Fat-to-heart crosstalk in health and disease. Front. Genet., 14.","DOI":"10.3389\/fgene.2023.990155"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Berm\u00fadez, V., Dur\u00e1n, P., Rojas, E., D\u00edaz, M.P., Rivas, J., Nava, M., Chac\u00edn, M., Cabrera De Bravo, M., Carrasquero, R., and Ponce, C.C. (2021). The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk with the Myocardium. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.735070"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12933-025-02946-8","article-title":"AI-quantified epicardial adipose tissue and prediction of future myocardial infarction in patients with cardiometabolic disease: A post-hoc analysis from the SCOT-HEART trial","volume":"24","author":"Geers","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1467-789X.2006.00293.x","article-title":"Epicardial fat: Properties, function and relationship to obesity","volume":"8","author":"Rabkin","year":"2007","journal-title":"Obes. Rev. Off. J. Int. Assoc. Study Obes."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jchf.2020.06.003","article-title":"Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure with Preserved Ejection Fraction","volume":"8","author":"Gorter","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure with Preserved Ejection Fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e145495","DOI":"10.1172\/jci.insight.145495","article-title":"Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation","volume":"6","author":"Vyas","year":"2021","journal-title":"JCI Insight"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1002\/mco2.413","article-title":"Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: Recent advances classified by research methodologies","volume":"4","author":"Song","year":"2023","journal-title":"MedComm"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCRESAHA.119.316251","article-title":"Reactivation of the Epicardium at the Origin of Myocardial Fibro-Fatty Infiltration During the Atrial Cardiomyopathy","volume":"126","author":"Suffee","year":"2020","journal-title":"Circ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mirabelli, M., Misiti, R., Sicilia, L., Brunetti, F.S., Chiefari, E., Brunetti, A., and Foti, D.P. (2024). Hypoxia in Human Obesity: New Insights from Inflammation towards Insulin Resistance-A Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25189802"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1091\/mbc.E18-01-0013","article-title":"Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface","volume":"31","author":"Brown","year":"2020","journal-title":"Mol. Biol. Cell"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Michel, L.Y.M. (2023). Extracellular Vesicles in Adipose Tissue Communication with the Healthy and Pathological Heart. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24097745"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.2147\/IJN.S511842","article-title":"Adipose Tissue-Derived Extracellular Vesicles Loaded with miR-141-3p Regulate Obesity-Induced Insulin Resistance by Targeting Glycogen Synthesis and Gluconeogenesis","volume":"20","author":"Wang","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102656","DOI":"10.1016\/j.jchf.2025.102656","article-title":"Adipoexosomal MicroRNAs as Adipose Tissue-Derived Messengers in Heart Failure with a Preserved Ejection Fraction","volume":"13","author":"Packer","year":"2025","journal-title":"JACC Heart Fail."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCRESAHA.125.325593","article-title":"Modulating the Secretome of Fat to Treat Heart Failure","volume":"136","author":"Salyer","year":"2025","journal-title":"Circ. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e70084","DOI":"10.1111\/imr.70084","article-title":"Cellular Senescence, Inflammaging and Cardiovascular Disease","volume":"337","author":"Zanders","year":"2026","journal-title":"Immunol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lefranc, C., Friederich-Persson, M., Foufelle, F., Nguyen Dinh Cat, A., and Jaisser, F. (2021). Adipocyte-Mineralocorticoid Receptor Alters Mitochondrial Quality Control Leading to Mitochondrial Dysfunction and Senescence of Visceral Adipose Tissue. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062881"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCRESAHA.124.325614","article-title":"Skeletal Muscle as a Mediator of Interorgan Crosstalk During Exercise: Implications for Aging and Obesity","volume":"136","author":"Shero","year":"2025","journal-title":"Circ. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e70097","DOI":"10.1002\/edm2.70097","article-title":"Irisin, the Myokine: Guardian and Mediator in Cardiovascular System","volume":"8","author":"Lan","year":"2025","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"123230","DOI":"10.1016\/j.lfs.2024.123230","article-title":"Targeting AMPK with Irisin: Implications for metabolic disorders, cardiovascular health, and inflammatory conditions\u2014A systematic review","volume":"360","author":"Laurindo","year":"2025","journal-title":"Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.metabol.2016.12.003","article-title":"The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1\/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia","volume":"68","author":"Li","year":"2017","journal-title":"Metab. Clin. Exp."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"32424","DOI":"10.1038\/srep32424","article-title":"FSTL1 as a Potential Mediator of Exercise-Induced Cardioprotection in Post-Myocardial Infarction Rats","volume":"6","author":"Xi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jshs.2020.11.010","article-title":"Dynamic resistance exercise increases skeletal muscle-derived FSTL1 inducing cardiac angiogenesis via DIP2A-Smad2\/3 in rats following myocardial infarction","volume":"10","author":"Xi","year":"2021","journal-title":"J. Sport Health Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102816","DOI":"10.1016\/j.arr.2025.102816","article-title":"Exerkines: Potential regulators of diabetic cardiomyopathy","volume":"110","author":"Yu","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/13813455.2025.2497272","article-title":"Meteorin-like protein (Metrnl): A key exerkine in exercise-mediated cardiovascular health","volume":"131","author":"Alizadeh","year":"2025","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e70046","DOI":"10.1111\/obr.70046","article-title":"Meteorin-Like Protein (Metrnl): An Exercise-Induced Myokine with Therapeutic Potential in Metabolic and Inflammatory Disorders","volume":"27","author":"Zhou","year":"2026","journal-title":"Obes. Rev. Off. J. Int. Assoc. Study Obes."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e13843","DOI":"10.1002\/jcsm.13843","article-title":"MyoMed205 Counteracts Titin Hyperphosphorylation and the Expression of Contraction-Regulating Proteins in a Rat Model of HFpEF","volume":"16","author":"Vahle","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/jcsm.12233","article-title":"Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia","volume":"8","author":"Bowen","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_41","first-page":"e945211","article-title":"Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects","volume":"30","author":"Liu","year":"2024","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1113\/JP280899","article-title":"Abnormal skeletal muscle blood flow, contractile mechanics and fibre morphology in a rat model of obese-HFpEF","volume":"599","year":"2021","journal-title":"J. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Vahle, B., Kldtke, R., Schauer, A., Bowen, T.S., Wislff, U., Linke, A., and Adams, V. (2025). Skeletal Muscle Alterations in Different Phenotypes of Heart Failure with Preserved Ejection Fraction. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136196"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jchf.2016.03.011","article-title":"Skeletal Muscle Mitochondrial Content, Oxidative Capacity, and Mfn2 Expression Are Reduced in Older Patients with Heart Failure and Preserved Ejection Fraction and Are Related to Exercise Intolerance","volume":"4","author":"Molina","year":"2016","journal-title":"JACC Heart Fail."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10741-016-9586-z","article-title":"Skeletal muscle bioenergetics in aging and heart failure","volume":"22","author":"Liu","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tem.2012.12.003","article-title":"Skeletal muscle aging and the mitochondrion","volume":"24","author":"Johnson","year":"2013","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ferri, E., Marzetti, E., Calvani, R., Picca, A., Cesari, M., and Arosio, B. (2020). Role of Age-Related Mitochondrial Dysfunction in Sarcopenia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155236"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCHEARTFAILURE.113.000406","article-title":"Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides","volume":"6","author":"Dai","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e46096","DOI":"10.1097\/MD.0000000000046096","article-title":"The impacts of sarcopenia and its components on heart failure patients: A systematic review and network meta-analysis","volume":"104","author":"Tran","year":"2025","journal-title":"Medicine"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lu, J., Gao, Y., Zhou, L., Peng, X., Feng, H., and Zheng, Z. (2025). Sarcopenia defined by multidimensional factors and its prognostic role in heart failure: A systematic review and meta-analysis. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1599572"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/iub.608","article-title":"The role of PGC-1 coactivators in aging skeletal muscle and heart","volume":"64","author":"Dillon","year":"2012","journal-title":"IUBMB Life"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"102347","DOI":"10.1016\/j.jacadv.2025.102347","article-title":"Skeletal Muscle-Cardiac Muscle Aging: Shared Mechanisms and Multimodal Interventions","volume":"4","author":"Kalra","year":"2025","journal-title":"JACC Adv."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jacbts.2024.11.006","article-title":"Proteostatic Imbalance Drives the Pathogenesis and Age-Related Exacerbation of Heart Failure with Preserved Ejection Fraction","volume":"10","author":"Kobak","year":"2025","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11886-025-02279-8","article-title":"Metabolic Regulation of Cardiovascular Aging","volume":"27","author":"Gao","year":"2025","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCRESAHA.123.324001","article-title":"Cardiovascular Consequences of Uremic Metabolites: An Overview of the Involved Signaling Pathways","volume":"134","author":"Curaj","year":"2024","journal-title":"Circ. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/CIRCRESAHA.124.325488","article-title":"Renal-Cardiac Crosstalk in the Pathogenesis and Progression of Heart Failure","volume":"136","author":"Noels","year":"2025","journal-title":"Circ. Res."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kaesler, N., Babler, A., Floege, J., and Kramann, R. (2020). Cardiac Remodeling in Chronic Kidney Disease. Toxins, 12.","DOI":"10.3390\/toxins12030161"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcmg.2020.04.021","article-title":"Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study","volume":"13","author":"Hayer","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"F452","DOI":"10.1152\/ajprenal.00266.2024","article-title":"Renal macro- and microcirculatory perturbations in acute kidney injury and chronic kidney disease associated with heart failure and cardiac surgery","volume":"328","author":"Marino","year":"2025","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13613-025-01609-x","article-title":"Ultrasound indicators of organ venous congestion: A narrative review","volume":"15","author":"Bitar","year":"2025","journal-title":"Ann. Intensive Care"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/sj.ki.5001846","article-title":"Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway","volume":"70","author":"Wolf","year":"2006","journal-title":"Kidney Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.ph.57.030195.001431","article-title":"Transforming growth factor-beta and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis?","volume":"57","author":"Ketteler","year":"1995","journal-title":"Annu. Rev. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Liu, J., Jia, Z., and Gong, W. (2021). Circulating Mitochondrial DNA Stimulates Innate Immune Signaling Pathways to Mediate Acute Kidney Injury. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.680648"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kuo, Y., Chen, L., Chen, Y., Chen, P., and Lin, H.Y. (2026). Mitochondrial Dysfunction at the Intersection of CKM Syndrome: Molecular Mechanisms and Path-to-Target Therapies. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27094120"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Sanada, F., Hayashi, S., and Morishita, R. (2025). Targeting the hallmarks of aging: Mechanisms and therapeutic opportunities. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1631578"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCRESAHA.125.325637","article-title":"Aging at the Crossroads of Organ Interactions: Implications for the Heart","volume":"136","author":"Sen","year":"2025","journal-title":"Circ. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"G79","DOI":"10.1152\/ajpgi.00120.2025","article-title":"Biomarkers of intestinal permeability are linked to incident cardiovascular diseases and cardiovascular events: A review of prospective studies","volume":"329","author":"Quirk","year":"2025","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"H1227","DOI":"10.1152\/ajpheart.00612.2020","article-title":"Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease","volume":"319","author":"Lewis","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Hermosillo, L.M., \u00c1vila-Soto, K.I., M\u00e9ndez-Garc\u00eda, L.A., C\u00e9rbulo-V\u00e1zquez, A., Esquivel-Vel\u00e1zquez, M., Bueno-Hern\u00e1ndez, N., Fonseca-S\u00e1nchez, M.\u00c1., and Escobedo, G. (2025). The molecular interplay among gut dysbiosis, adipose tissue, and metabolite-derived damage-associated molecular patterns in metainflammation and atherogenesis. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1694061"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"108991","DOI":"10.1016\/j.jnutbio.2022.108991","article-title":"Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism","volume":"105","author":"Anto","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1007\/s11010-025-05356-2","article-title":"The effect of TMAO on aging-associated cardiovascular and metabolic pathways and emerging therapies","volume":"480","author":"Alsulami","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Calvillo, L., Vanoli, E., Ferrara, F., and Caradonna, E. (2025). Interplay Among Gut Microbiota-Derived TMAO, Autonomic Nervous System Dysfunction, and Heart Failure Progression. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27010203"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.chom.2022.11.015","article-title":"Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease","volume":"31","author":"Zhu","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s43587-025-00864-8","article-title":"Gut microbiota-dependent increase in phenylacetic acid induces endothelial cell senescence during aging","volume":"5","author":"Pugin","year":"2025","journal-title":"Nat. Aging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"107794","DOI":"10.1016\/j.phrs.2025.107794","article-title":"Gut microbiota-derived metabolite phenylacetylglutamine in cardiovascular and metabolic diseases","volume":"217","author":"Chen","year":"2025","journal-title":"Pharmacol. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"ehaf784","DOI":"10.1093\/eurheartj\/ehaf784.930","article-title":"The gut microbiota metabolite phenylacetic acid regulates cardiac senescence through phenylacetylation modification of histones","volume":"46","author":"Xie","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","article-title":"A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors","volume":"180","author":"Nemet","year":"2020","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Anatskaya, O.V., Ponomartsev, S.V., Elmuratov, A.U., and Vinogradov, A.E. (2025). Transcriptome-Wide Insights: Neonatal Lactose Intolerance Promotes Telomere Damage, Senescence, and Cardiomyopathy in Adult Rat Heart. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26041584"},{"key":"ref_80","first-page":"20","article-title":"Early-life gut microbiome development and its potential long-term impact on health outcomes","volume":"4","author":"Borrego","year":"2025","journal-title":"Microbiome Res. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"102124","DOI":"10.1016\/j.molmet.2025.102124","article-title":"A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice","volume":"100","author":"Douros","year":"2025","journal-title":"Mol. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S2213-8587(21)00179-0","article-title":"Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: A randomised, double-blind, placebo-controlled, clinical trial","volume":"9","author":"Neeland","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"bvz42","DOI":"10.1210\/jendso\/bvz042","article-title":"Effects of Semaglutide Versus Dulaglutide on Epicardial Fat Thickness in Subjects with Type 2 Diabetes and Obesity","volume":"4","author":"Iacobellis","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2017.07.014","article-title":"Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress","volume":"264","author":"Yang","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","article-title":"Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction","volume":"21","author":"Nauck","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Rzepi\u0144ski, \u0141., Tywoniuk, A., Jaraczewska, J., Al-Shaer, A., and Wici\u0144ski, M. (2025). Beyond Diabetes: The Vasculoprotective Effects and Anti-Atherosclerotic Potential of Tirzepatide. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262412028"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jacc.2024.11.001","article-title":"Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy","volume":"85","author":"Kramer","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vph.2011.05.001","article-title":"Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1","volume":"55","author":"Fadini","year":"2011","journal-title":"Vasc. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12933-024-02539-x","article-title":"SGLT2 inhibition and adipose tissue metabolism: Current outlook and perspectives","volume":"23","author":"Morciano","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12933-024-02298-9","article-title":"Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure","volume":"23","author":"Kasperova","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12933-021-01228-3","article-title":"A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: The ASSET study","volume":"20","author":"Hiruma","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12933-023-02091-0","article-title":"Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes","volume":"22","author":"Cinti","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12933-017-0516-8","article-title":"Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: A pilot study","volume":"16","author":"Bouchi","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Soci, U.P.R., Cavalcante, B.R.R., Improta-Caria, A.C., and Roever, L. (2022). The Epigenetic Role of MiRNAs in Endocrine Crosstalk Between the Cardiovascular System and Adipose Tissue: A Bidirectional View. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.910884"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e14161","DOI":"10.14814\/phy2.14161","article-title":"Voluntary physical activity counteracts Chronic Heart Failure progression affecting both cardiac function and skeletal muscle in the transgenic Tg\u03b1q*44 mouse model","volume":"7","author":"Bardi","year":"2019","journal-title":"Physiol. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4079041","DOI":"10.1155\/2018\/4079041","article-title":"Short-Duration Swimming Exercise after Myocardial Infarction Attenuates Cardiac Dysfunction and Regulates Mitochondrial Quality Control in Aged Mice","volume":"2018","author":"Zhao","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11897-018-0408-6","article-title":"Impaired Exercise Tolerance in Heart Failure: Role of Skeletal Muscle Morphology and Function","volume":"15","author":"Tucker","year":"2018","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Campos, J.C., Queliconi, B.B., Dourado, P.M.M., Cunha, T.F., Zambelli, V.O., Bechara, L.R.G., Kowaltowski, A.J., Brum, P.C., Mochly-Rosen, D., and Ferreira, J.C.B. (2012). Exercise training restores cardiac protein quality control in heart failure. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052764"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"23705","DOI":"10.1002\/jcp.28939","article-title":"Postinfarction exercise training alleviates cardiac dysfunction and adverse remodeling via mitochondrial biogenesis and SIRT1\/PGC-1\u03b1\/PI3K\/Akt signaling","volume":"234","author":"Jia","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1152\/japplphysiol.00760.2012","article-title":"High- versus moderate-intensity aerobic exercise training effects on skeletal muscle of infarcted rats","volume":"114","author":"Moreira","year":"2013","journal-title":"J. Appl. Physiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3892\/mmr.2015.3669","article-title":"Effects of high-intensity interval versus continuous moderate-intensity aerobic exercise on apoptosis, oxidative stress and metabolism of the infarcted myocardium in a rat model","volume":"12","author":"Lu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lfs.2018.10.015","article-title":"Effects of different types of exercise on skeletal muscle atrophy, antioxidant capacity and growth factors expression following myocardial infarction","volume":"213","author":"Cai","year":"2018","journal-title":"Life Sci."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Armentaro, G., Cassano, V., Loiacono, P., Fuoco, C., Severini, G., Pastura, C.A., Panza, A., Panza, M., Mazza, E., and Miceli, S. (2025). Early Effect of Supplementation with Essential Amino Acids on Cardiac Performance in Elderly Patients with Heart Failure and Sarcopenia. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157533"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Sun, H., Wang, Q., Han, W., Chen, C., Wang, T., and Zhong, J. (2024). Iron deficiency: Prevalence, mortality risk, and dietary relationships in general and heart failure populations. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1342686"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Netzel, M.E., Dumler, C., Weber, N., Striegel, L., Rychlik, M., Hong, H.T., and O\u2019Hare, T. (2019). The Inside and out of Folate in Strawberries and Avocados. Proceedings, 36.","DOI":"10.3390\/proceedings2019036086"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Evangelista, L.S., Meraz, R., Wierenga, K.L., Nguyen, A.P., Angosta, A.D., and Kawi, J. (2025). High-Protein Dietary Interventions in Heart Failure: A Systematic Review of Clinical and Functional Outcomes. Nutrients, 17.","DOI":"10.3390\/nu17142361"},{"key":"ref_107","first-page":"496","article-title":"Effects of omega-3 fatty acids on skeletal muscle vascular health and metabolism","volume":"28","author":"Karimi","year":"2025","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_108","first-page":"741","article-title":"Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure","volume":"130","author":"Keceli","year":"2022","journal-title":"Circ. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/ejhf.70028","article-title":"Ferric derisomaltose augments intrinsic skeletal muscle electron transport chain activity in heart failure: A FERRIC-HF II molecular substudy","volume":"27","author":"Barakat","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_111","first-page":"CD12721","article-title":"Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction","volume":"5","author":"Martin","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: Known knowns and known unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2020.08.017","article-title":"Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure with Reduced Ejection Fraction Patients","volume":"9","author":"Srivastava","year":"2021","journal-title":"JACC Heart Fail"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.amjmed.2025.04.038","article-title":"Renin Angiotensin Inhibition and Lower Risk of Kidney Failure in Patients with Heart Failure","volume":"138","author":"Patel","year":"2025","journal-title":"Am. J. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/2047487318780035","article-title":"Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease","volume":"25","author":"Tsujimoto","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10741-025-10520-3","article-title":"The role of finerenone in the concomitant management of chronic kidney disease-type 2 diabetes and the implication for heart failure prevention and treatment","volume":"30","author":"Taub","year":"2025","journal-title":"Heart Fail. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCULATIONAHA.121.057983","article-title":"Finerenone Reduces Risk of Incident Heart Failure in Patients with Chronic Kidney Disease and Type 2 Diabetes: Analyses from the FIGARO-DKD Trial","volume":"145","author":"Filippatos","year":"2022","journal-title":"Circulation"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e36763","DOI":"10.1161\/JAHA.124.036763","article-title":"Characteristics, Predictors, and Clinical Outcomes in Heart Failure with Reduced Ejection Fraction According to a 1-Year Left Ventricular Ejection Fraction Following Sacubitril\/Valsartan Treatment","volume":"13","author":"Park","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Grigoriou, K., Karakasis, P., Nasoufidou, A., Stachteas, P., Klisic, A., Karagiannidis, E., Fyntanidou, B., Popovic, D.S., Patoulias, D., and Antoniadis, A.P. (2025). SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era. Medicina, 61.","DOI":"10.3390\/medicina61111903"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1080\/07853890.2020.1841281","article-title":"The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection","volume":"53","author":"Brown","year":"2021","journal-title":"Ann. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"Mcmurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_124","first-page":"2307","article-title":"Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"24","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_125","first-page":"783","article-title":"Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitors","volume":"21","author":"Lee","year":"2025","journal-title":"Nat. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tcm.2025.11.004","article-title":"Mechanistic insights and clinical horizons of SGLT2 inhibitors in heart failure management","volume":"36","author":"Vahid","year":"2026","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/s41440-025-02216-w","article-title":"Interaction between SGLT2 and the sympathetic nervous system in normal and various cardiovascular metabolic disease states","volume":"48","author":"Katsurada","year":"2025","journal-title":"Hypertens. Res."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Zhu, Z., Chen, A., Wang, M., Zhang, H., Dai, S., Liu, R., and Liu, J. (2025). Effects of probiotics on heart failure: A systematic review and meta-analysis. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1708678"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s12602-023-10105-2","article-title":"Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials","volume":"15","author":"Taslim","year":"2023","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Scisciola, L., Basilicata, M.G., Belmonte, M., Pesapane, A., Fontanella, R.A., Balzano, N., Palazzo, A.M.M., Joshi, R., Zia, A., and Tortorella, G. (2026). Dietary Nutrients, Gut Microbiota, and Cardiac Function: From Metabolic Mechanisms to Clinical Applications. Nutrients, 18.","DOI":"10.3390\/nu18030467"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Zhang, S., Li, J., Li, L., and Yuan, X. (2025). Gut microbiota on cardiovascular diseases-a mini review on current evidence. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1690411"},{"key":"ref_132","first-page":"157800","article-title":"Xin-Ji-Er-Kang alleviates heart failure induced by myocardial ischemia-reperfusion injury through reshaping gut microbiota and metabolites","volume":"151","author":"Gong","year":"2026","journal-title":"Phytomed. Int. J. Phyther. Phytopharm."},{"key":"ref_133","first-page":"1576","article-title":"Fecal Microbiota Transfer from Young Mice Reverts Vascular Aging Hallmarks and Metabolic Impairments in Aged Mice","volume":"16","author":"Cheng","year":"2024","journal-title":"Aging Dis."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Wang, P., Ding, L., Lang, Z., Zhang, Y., and Yu, Y. (2026). Therapeutic Modulation of the Gut Microbiome in Coronary Artery Disease: Current Evidence and Future Directions. Front. Biosci. (Landmark Ed.), 31.","DOI":"10.31083\/FBL45081"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.clinthera.2023.11.015","article-title":"The Effect of Fecal Microbiota Transplantation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis","volume":"46","author":"Pakmehr","year":"2024","journal-title":"Clin. Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coph.2019.04.008","article-title":"The dirty aspects of fecal microbiota transplantation: A review of its adverse effects and complications","volume":"49","author":"Dailey","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s12325-019-00974-x","article-title":"Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection","volume":"36","author":"Kim","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s13238-018-0541-8","article-title":"Microbiota transplantation: Concept, methodology and strategy for its modernization","volume":"9","author":"Zhang","year":"2018","journal-title":"Protein Cell"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1161\/HYP.0000000000000247","article-title":"Hypertension and the Gut Microbiome: A Science Advisory from the American Heart Association","volume":"82","author":"Yang","year":"2025","journal-title":"Hypertension"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40168-025-02118-6","article-title":"Fecal microbiota transplantation for hypertension: An exploratory, multicenter, randomized, blinded, placebo-controlled trial","volume":"13","author":"Fan","year":"2025","journal-title":"Microbiome"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: A comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.118.036652","article-title":"Short-Chain Fatty Acid Propionate Protects from Hypertensive Cardiovascular Damage","volume":"139","author":"Bartolomaeus","year":"2019","journal-title":"Circulation"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"101706","DOI":"10.1016\/j.arr.2022.101706","article-title":"Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases","volume":"81","author":"Hu","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s44161-022-00197-4","article-title":"Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial","volume":"2","author":"Jama","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Vijay, A., Astbury, S., Panayiotis, L., Marques, F.Z., Spector, T.D., Menni, C., and Valdes, A.M. (2021). Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.691564"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1161\/ATVBAHA.121.316533","article-title":"Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study","volume":"42","author":"Wang","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","article-title":"Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair","volume":"139","author":"Tang","year":"2019","journal-title":"Circulation"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"127824","DOI":"10.1016\/j.micres.2024.127824","article-title":"Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension","volume":"287","author":"Wang","year":"2024","journal-title":"Microbiol. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e2210","DOI":"10.1128\/mBio.02210-15","article-title":"Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota","volume":"7","author":"Chen","year":"2016","journal-title":"mBio"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Grigoriou, K., Lamprou, V., Antoniadis, A.P., Theofilis, P., Iliakis, P., Ktenopoulos, N., Apostolos, A., Nasoufidou, A., Fyntanidou, B., and Karagiannidis, E. (2026). Inflammasome-Driven Cardiac Fibrosis in Cardiometabolic Disease and Arrhythmias: Mechanisms, Biomarkers, and Therapeutic Targets. Front. Biosci. (Landmark Ed.), 31.","DOI":"10.31083\/FBL48667"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.tcm.2025.05.006","article-title":"Inflammasome and ventricular arrhythmogenesis: Pathogenic interplay and potential targets on the horizon","volume":"35","author":"Narducci","year":"2025","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2217\/epi-2023-0224","article-title":"Pathological epigenetic events and reversibility review: The intersection between hallmarks of aging and developmental origin of health and disease","volume":"15","author":"Ruden","year":"2023","journal-title":"Epigenomics"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"T105","DOI":"10.1530\/JOE-19-0009","article-title":"Epigenetic responses and the developmental origins of health and disease","volume":"242","author":"Goyal","year":"2019","journal-title":"J. Endocrinol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1471-0528.2008.01822.x","article-title":"Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life","volume":"115","author":"Painter","year":"2008","journal-title":"BJOG"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Wu, T., Zhang, W., Wang, Y., Luo, H., and Li, Y. (2025). The molecular mechanisms of IUGR programmed adulthood cardiovascular disease. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1589038"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1017\/S0033291720003566","article-title":"Evaluation of bi-directional causal association between depression and cardiovascular diseases: A Mendelian randomization study","volume":"52","author":"Li","year":"2022","journal-title":"Psychol. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pcad.2013.03.007","article-title":"An anxious heart: Anxiety and the onset of cardiovascular diseases","volume":"55","author":"Thurston","year":"2013","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1038\/s41380-025-03003-2","article-title":"Cardiovascular diseases and depression: A meta-analysis and Mendelian randomization analysis","volume":"30","author":"Zeng","year":"2025","journal-title":"Mol. Psychiatry"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6881\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:59:20Z","timestamp":1785761960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":159,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27156881"],"URL":"https:\/\/doi.org\/10.3390\/ijms27156881","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}